Overview

Prostatic Hyperplasia Treatment and Cancer Prevention

Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Treatment of patients with prostatic hyperplasia with topical papaverine.
Phase:
Early Phase 1
Details
Lead Sponsor:
Manchanda Medical Clinic
Treatments:
Papaverine